NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2080225052

Registered date:06/02/2020

Basic Information

Recruitment status completed
Health condition(s) or Problem(s) studied
Date of first enrollment22/01/2020
Target sample size60
Countries of recruitmentJapan,Asia except Japan
Study typeInterventional
Intervention(s)investigational material(s) Generic name etc : INN of investigational material : tasurgratinib Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcomeefficacy
Secondary Outcomeefficacy

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximumNot applicable
GenderBoth
Include criteria
Exclude criteria

Related Information

Contact

Public contact
Name
Address
Telephone
E-mail eisai-chiken_hotline@hhc.eisai.co.jp
Affiliation
Scientific contact
Name
Address
Telephone
E-mail eisai-chiken_hotline@hhc.eisai.co.jp
Affiliation